Dexamethasone nanotherapeutics for traumatic brain injury

Active Definitive Contract Awarded Last action

Contract number
HT942726CE012
Awardee
Awarding agency
Obligated
$1,286,279

Award facts

Opportunity
  • HQ003420RBDST Solicitation number
Contract value 100% obligated
$1,286,278.70 Current and potential, with all options
Completion date 23% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Greenville, SC 29609, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $0
Original award $1,286,279

About this award

The Defense Health Agency awarded a $1,286,278.70 definitive contract to Neurohope Therapeutics, Inc. for dexamethasone nanotherapeutics for traumatic brain injury on April 6, 2026, under a total small business set-aside.

Place of performance is Greenville, SC 29609. The contract runs through August 5, 2028 and is priced firm fixed price.

Quick answers

Who was awarded contract HT942726CE012?

HT942726CE012 was awarded to Neurohope Therapeutics, Inc. by Defense Health Agency (Department of Defense) on April 6, 2026.

How much is contract HT942726CE012 worth?

The government has obligated $1,286,279 on HT942726CE012.

Was contract HT942726CE012 competed?

The extent of competition for HT942726CE012 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award